Globeflex Capital L P Sells 16,242 Shares of Phibro Animal Health Corporation $PAHC

Globeflex Capital L P trimmed its stake in Phibro Animal Health Corporation (NASDAQ:PAHC) by 7.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 215,257 shares of the company’s stock after selling 16,242 shares during the period. Phibro Animal Health accounts for about 1.2% of Globeflex Capital L P’s investment portfolio, making the stock its 13th largest position. Globeflex Capital L P’s holdings in Phibro Animal Health were worth $8,042,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. 1620 Investment Advisors Inc. raised its stake in shares of Phibro Animal Health by 77.4% in the 4th quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company’s stock valued at $25,000 after acquiring an additional 295 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of Phibro Animal Health by 113.2% in the 4th quarter. Farther Finance Advisors LLC now owns 727 shares of the company’s stock valued at $27,000 after acquiring an additional 386 shares in the last quarter. Rothschild Investment LLC raised its stake in shares of Phibro Animal Health by 2,500.0% in the 4th quarter. Rothschild Investment LLC now owns 1,040 shares of the company’s stock valued at $39,000 after acquiring an additional 1,000 shares in the last quarter. Hughes Financial Services LLC bought a new position in shares of Phibro Animal Health in the 3rd quarter valued at approximately $40,000. Finally, iSAM Funds UK Ltd bought a new position in shares of Phibro Animal Health in the 3rd quarter valued at approximately $61,000. 99.34% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Citigroup cut their price objective on Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating on the stock in a research note on Thursday, May 14th. Zacks Research downgraded Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 21st. Morgan Stanley set a $49.00 price objective on Phibro Animal Health in a research note on Friday, February 6th. Wall Street Zen lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Weiss Ratings lowered Phibro Animal Health from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 8th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Phibro Animal Health currently has a consensus rating of “Hold” and an average target price of $38.80.

Phibro Animal Health Stock Up 3.9%

Shares of PAHC stock opened at $33.04 on Friday. Phibro Animal Health Corporation has a 12 month low of $22.85 and a 12 month high of $60.08. The firm has a market cap of $1.34 billion, a PE ratio of 14.18, a price-to-earnings-growth ratio of 0.48 and a beta of 0.46. The stock has a 50 day moving average of $46.67 and a 200-day moving average of $45.23. The company has a quick ratio of 1.26, a current ratio of 3.17 and a debt-to-equity ratio of 1.97.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.76 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. Phibro Animal Health had a return on equity of 37.14% and a net margin of 6.35%.The company had revenue of $383.54 million during the quarter, compared to analyst estimates of $367.02 million. Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. On average, equities analysts predict that Phibro Animal Health Corporation will post 3.07 EPS for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 24th. Stockholders of record on Wednesday, June 3rd will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, June 3rd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.5%. Phibro Animal Health’s payout ratio is 20.60%.

Insider Activity at Phibro Animal Health

In other news, CEO Jack Bendheim sold 10,560 shares of the company’s stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of $52.68, for a total transaction of $556,300.80. Following the completion of the transaction, the chief executive officer directly owned 80,360 shares in the company, valued at $4,233,364.80. The trade was a 11.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 74,928 shares of company stock worth $4,017,273 in the last three months. 50.13% of the stock is owned by insiders.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.